Pfizer
PFE
#134
Rank
โ‚ฌ123.85 B
Marketcap
21,78ย โ‚ฌ
Share price
-1.71%
Change (1 day)
-7.08%
Change (1 year)

Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.

Market capitalization of Pfizer (PFE)

Market cap: โ‚ฌ123.85 Billion

As of December 2025 Pfizer has a market cap of โ‚ฌ123.85 Billion. This makes Pfizer the world's 134th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pfizer from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ123.85 B-14.56%
2024โ‚ฌ144.96 B-1.42%
2023โ‚ฌ147.05 B-45.16%
2022โ‚ฌ268.13 B-8.38%
2021โ‚ฌ292.66 B75.93%
2020โ‚ฌ166.34 B-14.06%
2019โ‚ฌ193.55 B-11.27%
2018โ‚ฌ218.13 B21.23%
2017โ‚ฌ179.93 B-3.97%
2016โ‚ฌ187.38 B2.79%
2015โ‚ฌ182.30 B13.14%
2014โ‚ฌ161.12 B13.53%
2013โ‚ฌ141.92 B2.88%
2012โ‚ฌ137.95 B7.7%
2011โ‚ฌ128.09 B21.45%
2010โ‚ฌ105.47 B2.94%
2009โ‚ฌ102.45 B19.95%
2008โ‚ฌ85.42 B-18.84%
2007โ‚ฌ105.25 B-24.73%
2006โ‚ฌ139.83 B-3.5%
2005โ‚ฌ144.90 B-2.18%
2004โ‚ฌ148.13 B-30.8%
2003โ‚ฌ214.08 B18.8%
2002โ‚ฌ180.20 B-36.38%
2001โ‚ฌ283.23 B-8.13%
2000โ‚ฌ308.30 B148.61%
1999โ‚ฌ124.01 B-9.02%
1998โ‚ฌ136.30 B67.65%
1997โ‚ฌ81.30 B80.23%
1996โ‚ฌ45.11 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Pfizer was reported to be:

โ‚ฌ126.08 Billion
by Nasdaq info icon info icon
โ‚ฌ126.00 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
โ‚ฌ208.12 B 68.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ414.31 B 234.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ88.67 B-28.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ757.24 B 511.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ216.18 B 74.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
โ‚ฌ82.34 B-33.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Amgen
AMGN
โ‚ฌ145.34 B 17.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ181.48 B 46.53%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ239.50 B 93.37%๐Ÿ‡ฌ๐Ÿ‡ง UK